187 related articles for article (PubMed ID: 26299612)
1. The metastatic infiltration at the metastasis/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study.
Siam L; Bleckmann A; Chaung HN; Mohr A; Klemm F; Barrantes-Freer A; Blazquez R; Wolff HA; Lüke F; Rohde V; Stadelmann C; Pukrop T
Oncotarget; 2015 Oct; 6(30):29254-67. PubMed ID: 26299612
[TBL] [Abstract][Full Text] [Related]
2. Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.
Collaud S; Stahel R; Inci I; Hillinger S; Schneiter D; Kestenholz P; Weder W
Lung Cancer; 2012 Dec; 78(3):234-8. PubMed ID: 23040415
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
[TBL] [Abstract][Full Text] [Related]
4. Tumor, node and metastasis classification of lung cancer--M1a versus M1b--analysis of M descriptors and other prognostic factors.
Sánchez de Cos Escuín J; Abal Arca J; Melchor Íñiguez R; Miravet Sorribes L; Núñez Ares A; Hernández Hernández JR; García Arangüena L; Núñez Delgado M; Pavón Fernández MJ; Francisco Corral G; de Esteban Júlvez L; González Budiño MT; Abad Cavaco F; Ansótegui Barrera E; Andreo García F; Serra Mitjans M; Hernández Rodríguez H
Lung Cancer; 2014 May; 84(2):182-9. PubMed ID: 24629637
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
6. Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.
Griffioen GH; Toguri D; Dahele M; Warner A; de Haan PF; Rodrigues GB; Slotman BJ; Yaremko BP; Senan S; Palma DA
Lung Cancer; 2013 Oct; 82(1):95-102. PubMed ID: 23973202
[TBL] [Abstract][Full Text] [Related]
7. Trastuzumab for HER2+ metastatic breast cancer in clinical practice: Cardiotoxicity and overall survival.
Rossi M; Carioli G; Bonifazi M; Zambelli A; Franchi M; Moja L; Zambon A; Corrao G; La Vecchia C; Zocchetti C; Negri E
Eur J Cancer; 2016 Jan; 52():41-9. PubMed ID: 26630533
[TBL] [Abstract][Full Text] [Related]
8. Coculture system with an organotypic brain slice and 3D spheroid of carcinoma cells.
Chuang HN; Lohaus R; Hanisch UK; Binder C; Dehghani F; Pukrop T
J Vis Exp; 2013 Oct; (80):. PubMed ID: 24145580
[TBL] [Abstract][Full Text] [Related]
9. B7-H1 and B7-H3 are independent predictors of poor prognosis in patients with non-small cell lung cancer.
Mao Y; Li W; Chen K; Xie Y; Liu Q; Yao M; Duan W; Zhou X; Liang R; Tao M
Oncotarget; 2015 Feb; 6(5):3452-61. PubMed ID: 25609202
[TBL] [Abstract][Full Text] [Related]
10. Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study.
Hendriks LE; Derks JL; Postmus PE; Damhuis RA; Houben RM; Troost EG; Hochstenbag MM; Smit EF; Dingemans AM
Eur J Cancer; 2015 Nov; 51(17):2534-44. PubMed ID: 26323530
[TBL] [Abstract][Full Text] [Related]
11. Reduced local recurrence of a single brain metastasis through microscopic total resection.
Yoo H; Kim YZ; Nam BH; Shin SH; Yang HS; Lee JS; Zo JI; Lee SH
J Neurosurg; 2009 Apr; 110(4):730-6. PubMed ID: 19072310
[TBL] [Abstract][Full Text] [Related]
12. Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?
Alsan Cetin I; Akgun Z; Atasoy BM; Fulden Yumuk P; Abacioglu U
J BUON; 2013; 18(2):453-8. PubMed ID: 23818361
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of primary lung cancer with synchronous brain metastases.
Billing PS; Miller DL; Allen MS; Deschamps C; Trastek VF; Pairolero PC
J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
[TBL] [Abstract][Full Text] [Related]
14. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
15. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
[TBL] [Abstract][Full Text] [Related]
16. Gamma Knife surgery for metastatic brain tumors from primary breast cancer: treatment indication based on number of tumors and breast cancer phenotype.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2010 Dec; 113 Suppl():65-72. PubMed ID: 21121788
[TBL] [Abstract][Full Text] [Related]
17. Volumetric response to radiosurgery for brain metastasis varies by cell of origin.
Iyer A; Harrison G; Kano H; Weiner GM; Luther N; Niranjan A; Flickinger JC; Lunsford LD; Kondziolka D
J Neurosurg; 2014 Sep; 121(3):564-9. PubMed ID: 24878286
[TBL] [Abstract][Full Text] [Related]
18. Increased survival with the combination of stereotactic radiosurgery and gefitinib for non-small cell lung cancer brain metastasis patients: a nationwide study in Taiwan.
Lin CH; Hsu KH; Chang SN; Tsou HK; Sheehan J; Sheu ML; Pan HC
Radiat Oncol; 2015 Jun; 10():127. PubMed ID: 26048754
[TBL] [Abstract][Full Text] [Related]
19. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center Thoracic Surgical Staff.
Burt M; Wronski M; Arbit E; Galicich JH
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):399-410; discussion 410-1. PubMed ID: 1312184
[TBL] [Abstract][Full Text] [Related]
20. Number of metastatic sites is a strong predictor of survival in patients with nonsmall cell lung cancer with or without brain metastases.
Oh Y; Taylor S; Bekele BN; Debnam JM; Allen PK; Suki D; Sawaya R; Komaki R; Stewart DJ; Karp DD
Cancer; 2009 Jul; 115(13):2930-8. PubMed ID: 19441110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
